D
Dinan Abdelatif
Researcher at Inova Fairfax Hospital
Publications - 9
Citations - 6772
Dinan Abdelatif is an academic researcher from Inova Fairfax Hospital. The author has contributed to research in topics: Medicine & Fatty liver. The author has an hindex of 3, co-authored 5 publications receiving 4197 citations. Previous affiliations of Dinan Abdelatif include Inova Health System.
Papers
More filters
Journal ArticleDOI
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
Zobair M. Younossi,Zobair M. Younossi,Aaron B. Koenig,Dinan Abdelatif,Yousef Fazel,Linda Henry,Mark Wymer,Mark Wymer +7 more
TL;DR: As the global epidemic of obesity fuels metabolic conditions, the clinical and economic burden of NAFLD will become enormous, and random‐effects models were used to provide point estimates of prevalence, incidence, mortality and incidence rate ratios.
Journal ArticleDOI
Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis
Michael Estep,Michael Estep,Rohini Mehta,Rohini Mehta,Gary Bratthauer,Lakshmi Alaparthi,Lakshmi Alaparthi,Fanny Monge,Fanny Monge,Simon Ali,Dinan Abdelatif,Zahra Younoszai,Maria Stepanova,Zachary Goodman,Zachary Goodman,Zobair M. Younossi,Zobair M. Younossi +16 more
TL;DR: The findings show quantitation of SHH expression by CAM can provide a tool for quantifying changes in hepatocyte injury and assist in unambiguous staging/grading of NASH.
Journal ArticleDOI
An exploratory study examining how nano-liquid chromatography–mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease
Zobair M. Younossi,Zobair M. Younossi,Azza Karrar,Azza Karrar,Mariaelena Pierobon,Aybike Birerdinc,Maria Stepanova,Maria Stepanova,Dinan Abdelatif,Dinan Abdelatif,Zahra Younoszai,Thomas Jeffers,Sean Felix,Kianoush Jeiran,Alex Hodge,Weidong Zhou,Fanny Monge,Fanny Monge,Lakshmi Alaparthi,Lakshmi Alaparthi,Vikas Chandhoke,Vikas Chandhoke,Zachary Goodman,Zachary Goodman,Emanuel F. Petricoin +24 more
TL;DR: Simultaneous profiling of serum proteome and hepatic phosphoproteome reveals that the activation of ASK1 S38, p38 MAPK in the liver, and serum α2M and coagulation factor V are independently associated with hepatic collagen deposition in patients with NASH.
Journal ArticleDOI
Major Histocompatibility Complex Class I‐Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease
Azza Karrar,Bijal Rajput,Siddharth Hariharan,Dinan Abdelatif,Mohamad Houry,Ali Moosvi,Irfan Ali,Daisong Tan,Sohailla Noor,Donna Esmaeili,Sean Felix,Lakshmi Alaparthi,Munkhzul Otgonsuren,Brian Lam,Zachary Goodman,Zobair M. Younossi +15 more
TL;DR: MICA alleles may be associated with NASH and its histologic features of inflammation and fibrosis and additional research is required to investigate the potential role of MICA in increased risk or protection against NAFLD.
Journal ArticleDOI
Serum Amyloid A Is Strongly Associated With Hyperlipidemia in Patients With Non-alcoholic Fatty Liver Disease (NAFLD): 2090
Azza Karrar,Dinan Abdelatif,Irfan Ali,Mohamad Houry,Siddharth Hariharan,Khatera Salam,Sara Kim,Sreya Addanki,Zahra Younoszai,Munkhzul Otgonsuren,Zachary Goodman,Zobair M. Younossi +11 more
TL;DR: HCC DNA markers can be detected in urine of patients with HCC by short-amplicon, PCR-based assays and in combination with serum AFP, three biomarker urine DNA testing detected at least 30% more HCC in an open-labeled study compared to serum AFP alone.